Our Mission

The mission of the Center for Health Care Research and Policy is to:
  1. improve the health of the public by conducting research that examines access to health care, increases the quality of health care services, and informs health policy and practice; and
  2. lead educational programs that promote these goals.

New Study of Heart Rate and Mortality Risk

By | October 10, 2017

Love_Thomas6235
Dr. Thomas E. Love has collaborated on a new study, “Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction“. Among older hospitalized patients with heart failure with preserved ejection fraction (HFpEF), a lower heart rate at discharge is associated with a lower risk of all-cause mortality, but not with lower HF-related or all-cause readmission, according to a study published Oct. 2 in the Journal of the American College of Cardiology. A lower heart rate is associated with better outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). Less is known about this association in patients with HF with preserved ejection fraction (HFpEF). Using data from the Medicare-linked OPTIMIZE-HF study, a group led by Phillip H. Lam and Daniel J. Dooley, and including Dr. Love, examined the associations of discharge heart rate with outcomes in 8,873 hospitalized patients with HFpEF. During a six-year follow-up, all-cause mortality for matched patients was 65 percent for those with a discharge heart rate <70 beats/min vs. 70 percent for those with ≥70 beats/min. A heart rate below 70 beats/min was also associated with a lower risk for the combined endpoint of HF readmission or all-cause mortality. Subgroup analyses demonstrated that the beneficial association between heart rate <70 beats/min and all-cause mortality was similar across various clinically relevant subgroups of patients, including those by baseline atrial fibrillation and beta-blocker use. “These findings suggest that the beneficial association of a lower heart rate and improved survival observed in patients with HFrEF [HF with reduced ejection fraction] might extend to those with HFpEF,” the study authors write. “Future studies are needed to develop and test interventions that might improve outcomes in patients with HFpEF and elevated heart rate.” Read details from the American College of Cardiology.

 

Researchers Combine EHR and Neighborhood Data to Improve Cardiovascular Risk Prediction

By | August 28, 2017


photo_roach
Center researchers have published a landmark article demonstrating that neighborhood disadvantage is a powerful predictor of cardiovascular outcomes. Cleveland Clinic Statistician Dr. Jarrod Dalton, a Senior Scholar in the Center, was joined by Center Faculty including Dr. Perzynski, Dr. Einstadter and Dr. Dawson in authoring this important work in Annals of Internal Medicine. The study uses electronic health record (EHR) data and is a clear example of how interdisciplinary researchers can come together and examine how social and clinical factors combine to shape population health.

Dr. Roach receives 2017 Chair Award for Contributions in Research in Rehabilitation

By | June 15, 2017


photo_roach
On June 11, 2017 at the MetroHealth Rehabilitation Institute’s Annual Recognition, Graduation and Awards Dinner Dr. Roach was awarded the Chair Award for Contributions in Research. She has been a researcher and sociologist at MetroHealth since 1989. This year, she and co-Principal Investigator Dr. Greg Neumenatis were again awarded a national Spinal Cord Injury Model Systems grant.Among  her contributions are publications in PM&R on preventive health care among persons with spinal cord injury and early predictors of functioning after trauma.

Cleveland City Council Hears Testimony on Broadband Internet as a Social Determinant of Health

By | June 5, 2017

Perzynski Cleveland CouncilDr. Perzynski, together with Dr. Amy Sheon,  and among representatives of multiple community organizations, gave invited testimony at a special hearing of Cleveland City Council.  The hearing was reported on at Cleveland Scene in the story, “Strapped with Low Internet Access, Cleveland Takes a Close Look at How to Solve Digital Divide.”  At the hearing, Dr. Perzynski presented findings from research recently published in the Journal of the American Medical Informatics Association.

Landmark study of Under-diagnosis and Under-treatment of Hypertension in U.S. Kids

By | November 22, 2016

Hypertension is already nicknamed “the silent killer”, and for children and adolescents ages 3 -18, it could easily be called the under-diagnosed disease based on the results of a study published today in Pediatrics. The report’s lead author, Dr. David Kaelber, Chief Medical Informatics Officer at MetroHealth and Director of Health Care Informatics at the Center for Health Care Research and Policy explains the results here. Even though children’s blood pressure is routinely checked during office visits, physicians aren’t interpreting the results and following the appropriate guidelines for treatment…

Bolen and colleagues find newer diabetes drugs to be no safer than older drugs

By | November 9, 2016

In an article published on June 7th, 2016 in the Annals of Internal Medicine, Dr. Shari Bolen and colleagues from Johns Hopkins University compare the effectiveness and safety of most diabetes medications alone and in combination with metformin.  They found that metformin, one of the older medications, is still the safest and most effective diabetes medication…

New study finds heart failure readmission associated with poorer long-term outcomes and cost for Medicare patients

By | November 1, 2016

In a study of more than 7500 Medicare beneficiaries hospitalized for heart failure in 1998-2001, 30-day all-cause readmission was associated with a higher risk of subsequent all-cause mortality, higher number of cumulative all-cause readmission, longer cumulative length of stay, and higher cumulative cost. Published this month in the American Journal of Medicine. the study, led by researchers at the Veterans Affairs Medical Center of Washington, DC, was co-authored by Dr. Thomas Love, director of Biostatistics and Evaluation for the Center for Health Care Research and Policy…